Hudson Alakonya is the lead founder member of ICRF Kenya and oversees its overall leadership and management. He is also Postdoctoral Fellow at Tuveson Lab, Cold Spring Harbor Laboratory, working to develop theranostics for PET imaging and targeted radionuclide therapy for PDAC patients. Hudson holds a Ph.D. in Oncology from the University of Oxford (UK), MSc in Cancer from University College London (UK) and BTech Industrial Microbiology and Biotechnology from Technical University of Mombasa (Kenya).